OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

SB 25-048 - Requires Large-Group Health Insurance Plans in Colorado to Offer Consumers Plans that Cover Glucagon-like Peptide-1 medications, Known as GLP-1 Drugs, to Treat Obesity and Pre-Diabetes - Colorado Key Vote

Timeline

Related Issues

Stage Details

Title: Requires Large-Group Health Insurance Plans in Colorado to Offer Consumers Plans that Cover Glucagon-like Peptide-1 medications, Known as GLP-1 Drugs, to Treat Obesity and Pre-Diabetes

Signed by Governor Jared Polis


See How Your Politicians Voted

Title: Requires Large-Group Health Insurance Plans in Colorado to Offer Consumers Plans that Cover Glucagon-like Peptide-1 medications, Known as GLP-1 Drugs, to Treat Obesity and Pre-Diabetes

Vote Smart's Synopsis:

Vote to concur with House amendments and pass a bill that requires large-group health insurance plans in Colorado to offer consumers a plan that covers Glucagon-like peptide-1 medications, known as GLP-1 drugs, to treat obesity and pre-diabetes.

Highlights:

  • Requires large-group health insurance plans in Colorado to offer consumers a plan that covers Glucagon-like peptide-1 medications, known as GLP-1 drugs, to treat obesity and pre-diabetes (Sec. 1-4)

  • Requires large group health benefit plans to provide coverage for the treatment of the chronic disease of obesity and the treatment of pre-diabetes, including coverage for the national diabetes prevention program, medical nutrition therapy, intensive behavioral or lifestyle therapy, metabolic and bariatric surgery (Sec. 1-4).

  • Requires carriers to offer the policyholder the option to purchase coverage for FDA-approved anti-obesity medications, including at least one FDA-approved GLP-1 medication (Sec. 1-4).

  • Specifies that the provisions of this bill shall take effect beginning January 1, 2027 (Sec. 5).

Full Bill Text

See How Your Politicians Voted

Title: Requires Large-Group Health Insurance Plans in Colorado to Offer Consumers Plans that Cover Glucagon-like Peptide-1 medications, Known as GLP-1 Drugs, to Treat Obesity and Pre-Diabetes

Vote Smart's Synopsis:

Vote to amend and pass a bill that requires large-group health insurance plans in Colorado would have to offer consumers a plan that covers Glucagon-like peptide-1 medications, known as GLP-1 drugs, to treat obesity and pre-diabetes.

Highlights:

  • Requires large-group health insurance plans in Colorado to offer consumers a plan that covers Glucagon-like peptide-1 medications, known as GLP-1 drugs, to treat obesity and pre-diabetes (Sec. 1-4)

  • Requires large group health benefit plans to provide coverage for the treatment of the chronic disease of obesity and the treatment of pre-diabetes, including coverage for the national diabetes prevention program, medical nutrition therapy, intensive behavioral or lifestyle therapy, metabolic and bariatric surgery (Sec. 1-4).

  • Requires carriers to offer the policyholder the option to purchase coverage for FDA-approved anti-obesity medications, including at least one FDA-approved GLP-1 medication (Sec. 1-4).

  • Specifies that the provisions of this bill shall take effect beginning January 1, 2027 (Sec. 5).

Full Bill Text

Title: Requires Large-Group Health Insurance Plans in Colorado to Offer Consumers Plans that Cover Glucagon-like Peptide-1 medications, Known as GLP-1 Drugs, to Treat Obesity and Pre-Diabetes

Title: Requires Large-Group Health Insurance Plans in Colorado to Offer Consumers Plans that Cover Glucagon-like Peptide-1 medications, Known as GLP-1 Drugs, to Treat Obesity and Pre-Diabetes

arrow_upward